Cargando…
Cell therapy as a treatment of secondary lymphedema: a systematic review and meta-analysis
BACKGROUND: Lymphedema, the accumulation of interstitial fluid caused by poor lymphatic drainage, is a progressive and permanent disease with no curative treatment. Several studies have evaluated cell-based therapies in secondary lymphedema, but no meta-analysis has been performed to assess their ef...
Autores principales: | Lafuente, Hector, Jaunarena, Ibon, Ansuategui, Eukene, Lekuona, Arantza, Izeta, Ander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605543/ https://www.ncbi.nlm.nih.gov/pubmed/34801084 http://dx.doi.org/10.1186/s13287-021-02632-y |
Ejemplares similares
-
Photonic Technology for In Vivo Monitoring of Hypoxia–Ischemia
por: Olaetxea, Ion, et al.
Publicado: (2022) -
Transperitoneal vs extraperitoneal approach for aortic sentinel node detection in endometrial cancer
por: Gorostidi, Mikel, et al.
Publicado: (2022) -
Systematic review: conservative treatments for secondary lymphedema
por: Oremus, Mark, et al.
Publicado: (2012) -
Tumor necrosis factor alpha drugs in rheumatoid arthritis: systematic review and metaanalysis of efficacy and safety
por: Alonso-Ruiz, Alberto, et al.
Publicado: (2008) -
Pharmacological Treatment of Secondary Lymphedema
por: Brown, Stav, et al.
Publicado: (2022)